$70.50
Manufacturer: Netherlands
Purpose: Inhibits topoisomerase II to treat cancers like lung and testicular tumors.
Description
Etopozid-TEVA (etoposide) concentrate for infusions 20 mg/ml. 10 ml. №1 vial
Ingredients:
Each ml contains 20 mg of etoposide as the active ingredient.
Dosage:
The dosage of Etopozid-TEVA should be determined by a healthcare provider based on the patient’s condition and response to treatment. It is typically administered intravenously over a specific period.
Indications:
Etopozid-TEVA is indicated for the treatment of various types of cancer, including lung cancer, testicular cancer, and lymphomas. It works by slowing or stopping the growth of cancer cells in the body.
Contraindications:
Do not use Etopozid-TEVA if you are allergic to etoposide or any other ingredients in the product. It is important to discuss any existing medical conditions or medications with your healthcare provider before starting treatment.
Directions:
Etopozid-TEVA should only be administered by healthcare professionals experienced in the use of cancer chemotherapeutic agents. The infusion should be given slowly to minimize the risk of side effects.
Scientific Evidence:
Etoposide, the active ingredient in Etopozid-TEVA, has been extensively studied for its efficacy in treating various types of cancer. Research has shown that etoposide is effective in inhibiting topoisomerase II, an enzyme that is essential for DNA replication in cancer cells. This action leads to cell death and helps in the regression of tumors.
Additional Information:
In clinical trials, Etopozid-TEVA has demonstrated significant antitumor activity and has been well-tolerated by patients. The drug’s mechanism of action, targeting rapidly dividing cancer cells, makes it a valuable component in cancer treatment regimens. It is important to follow the prescribed dosage and administration guidelines to maximize the benefits of Etopozid-TEVA therapy.
Overall, Etopozid-TEVA (etoposide) concentrate for infusions is a crucial medication in the oncology field, offering a targeted approach to combating cancer cells. Its well-established efficacy and safety profile make it a preferred choice in the treatment of various malignancies.
Recent Reviews